Marshall Wace’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.26M | Sell |
2,292,449
-20,477
| -0.9% | -$29.1K | ﹤0.01% | 1232 |
|
|
2025
Q1 | $3.54M | Sell |
2,312,926
-321,139
| -12% | -$491K | ﹤0.01% | 1131 |
|
|
2024
Q4 | $6.53M | Buy |
+2,634,065
| New | +$6.53M | 0.01% | 876 |
|
|
2023
Q3 | – | Sell |
-30,423
| Closed | -$315K | – | 1792 |
|
|
2023
Q2 | $315K | Buy |
+30,423
| New | +$315K | ﹤0.01% | 1707 |
|
|
2021
Q4 | – | Sell |
-13,619
| Closed | -$245K | – | 3101 |
|
|
2021
Q3 | $245K | Buy |
+13,619
| New | +$245K | ﹤0.01% | 2142 |
|
|
2021
Q2 | – | Sell |
-36,612
| Closed | -$923K | – | 2054 |
|
|
2021
Q1 | $923K | Buy |
+36,612
| New | +$923K | ﹤0.01% | 1428 |
|
|
2019
Q2 | – | Sell |
-17,245
| Closed | -$103K | – | 1263 |
|
|
2019
Q1 | $103K | Buy |
+17,245
| New | +$103K | ﹤0.01% | 1420 |
|
|
2017
Q1 | – | Sell |
-466,734
| Closed | -$12.7M | – | 298 |
|
|
2016
Q4 | $12.7M | Buy |
466,734
+345,934
| +286% | +$9.39M | 0.08% | 278 |
|
|
2016
Q3 | $3.09M | Buy |
+120,800
| New | +$3.09M | 0.02% | 507 |
|